Meeting
Abstract Number: A8
SHM Converge 2022
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as the presence of ≥5% of hepatic steatosis (HS) in the absence of other liver disorders, such as chronic viral or autoimmune hepatitis, steatosis induced by drugs, significant alcohol consumption, hemochromatosis, or Wilson’s disease. There is limited literature describing national prevalence and epidemiological characteristics of NAFLD in […]
Abstract Number: D10
SHM Converge 2022
Background: Alcohol withdrawal syndrome is a clinical syndrome with clinical manifestations of anxiety, insomnia, irritability, disorientation, hallucinations, seizures, and autonomic hyperactivity. Delirium tremens is the most severe manifestation of alcohol withdrawal. Although benzodiazepines are currently the first line for treatment of alcohol withdrawal, barbiturates are increasingly used for treatment as an alternative[1–3]. We need strong […]
Abstract Number: F34
SHM Converge 2022
Case Presentation: A 23 year old man with type 2 autoimmune pancreatitis (AIP) based on suggestive pancreatic biopsy presented with abdominal pain, nausea, and vomiting. Based on his AIP diagnosis, he had previously received courses of steroids and azathioprine, celiac plexus block, minor papilla sphincterotomy, and pancreatic duct stent placement, but these were all ineffective. […]